Full text
PDFPage 788
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Corsini G. U., Del Zompo M., Gessa G. L., Mangoni A. Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease. Lancet. 1979 May 5;1(8123):954–956. doi: 10.1016/s0140-6736(79)91725-2. [DOI] [PubMed] [Google Scholar]
- Quinn N., Illas A., Lhermitte F., Agid Y. Bromocriptine and domperidone in the treatment of Parkinson disease. Neurology. 1981 Jun;31(6):662–667. doi: 10.1212/wnl.31.6.662. [DOI] [PubMed] [Google Scholar]
- Schachter M., Bédard P., Debono A. G., Jenner P., Marsden C. D., Price P., Parkes J. D., Keenan J., Smith B., Rosenthaler J. The role of D-1 and D-2 receptors. Nature. 1980 Jul 10;286(5769):157–159. doi: 10.1038/286157a0. [DOI] [PubMed] [Google Scholar]
- Schachter M., Sheehy M. P., Parkes J. D., Marsden C. D. Lisuride in the treatment of Parkinsonism. Acta Neurol Scand. 1980 Dec;62(6):382–385. doi: 10.1111/j.1600-0404.1980.tb03050.x. [DOI] [PubMed] [Google Scholar]
- Shindler J. S., Finnerty G. T., Towlson K., Dolan A. L., Davies C. L., Parkes J. D. Domperidone and levodopa in Parkinson's disease. Br J Clin Pharmacol. 1984 Dec;18(6):959–962. doi: 10.1111/j.1365-2125.1984.tb02571.x. [DOI] [PMC free article] [PubMed] [Google Scholar]